Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.


Journal Article

BACKGROUND: Recently, epidemiological and clinical data have revealed important changes with regard to clinical adenovirus infection, including alterations in antigenic presentation, geographical distribution, and virulence of the virus. METHODS: In an effort to better understand the epidemiology of clinical adenovirus infection in the United States, we adopted a new molecular adenovirus typing technique to study clinical adenovirus isolates collected from 22 medical facilities over a 25-month period during 2004-2006. A hexon gene sequence typing method was used to characterize 2237 clinical adenovirus-positive specimens, comparing their sequences with those of the 51 currently recognized prototype human adenovirus strains. In a blinded comparison, this method performed well and was much faster than the classic serologic typing method. RESULTS: Among civilians, the most prevalent adenovirus types were types 3 (prevalence, 34.6%), 2 (24.3%), 1 (17.7%), and 5 (5.3%). Among military trainees, the most prevalent types were types 4 (prevalence, 92.8%), 3 (2.6%), and 21 (2.4%). CONCLUSIONS: For both populations, we observed a statistically significant increasing trend of adenovirus type 21 detection over time. Among adenovirus isolates recovered from specimens from civilians, 50% were associated with hospitalization, 19.6% with a chronic disease condition, 11% with a bone marrow or solid organ transplantation, 7.4% with intensive care unit stay, and 4.2% with a cancer diagnosis. Multivariable risk factor modeling for adenovirus disease severity found that age <7 years (odds ratio [OR], 3.2; 95% confidence interval [CI], 1.4-7.4), chronic disease (OR, 3.6; 95% CI, 2.6-5.1), recent transplantation (OR, 2.7; 95% CI, 1.3-5.2), and adenovirus type 5 (OR, 2.7; 95% CI, 1.5-4.7) or type 21 infection (OR, 7.6; 95% CI, 2.6-22.3) increased the risk of severe disease.

Full Text

Duke Authors

Cited Authors

  • Gray, GC; McCarthy, T; Lebeck, MG; Schnurr, DP; Russell, KL; Kajon, AE; Landry, ML; Leland, DS; Storch, GA; Ginocchio, CC; Robinson, CC; Demmler, GJ; Saubolle, MA; Kehl, SC; Selvarangan, R; Miller, MB; Chappell, JD; Zerr, DM; Kiska, DL; Halstead, DC; Capuano, AW; Setterquist, SF; Chorazy, ML; Dawson, JD; Erdman, DD

Published Date

  • November 1, 2007

Published In

Volume / Issue

  • 45 / 9

Start / End Page

  • 1120 - 1131

PubMed ID

  • 17918073

Pubmed Central ID

  • 17918073

Electronic International Standard Serial Number (EISSN)

  • 1537-6591

Digital Object Identifier (DOI)

  • 10.1086/522188


  • eng

Conference Location

  • United States